Recent News

Philadelphia officials warned former patients of a Rittenhouse Square dental practice to get tested for HIV, hepatitis B, and hepatitis C after infection-control concerns, turning a local clinic story into a public-trust problem.

The Trump administration said many foreigners already in the U.S. must leave and apply for green cards abroad, a surprise shift that could turn legal status into a procedural risk.

The anti-weaponization fund may be sold as relief for abuse, but its structure turns legitimate grievances into a fight over taxpayer money and executive power.

London’s live facial-recognition rollout shows how public safety tools can quietly normalize biometric identity checks for everyone walking down the street.

Gilead’s first U.S.-approved hepatitis D treatment fills a real medical gap, but accelerated approval also puts public trust on the follow-through study.

The Justice Department’s proposed $1.8 billion compensation fund shows how fast anti-weaponization politics can become another unaccountable slush-fund fight.

Meta’s alleged employee-monitoring push shows how the AI race can turn ordinary knowledge work into raw material for the next automation cycle.

Hospitals say CVS diverted $250 million in 340B savings, turning a safety-net drug program into another fight over healthcare middlemen.

Trump shelved an AI risk-review order at the last minute, exposing the tension between cybersecurity warnings and the pressure to keep America’s AI lead over China.

New U.S. Ebola screening rules and unrest around a DRC treatment center show that outbreak response depends as much on public trust and execution capacity as on official restrictions.